Next-Gen Pleural Diseases : Market Forecast, Transformation, and Long-Term Trajectories
Discover trends, market shifts, and competitive outlooks for the pleural diseases industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Pleural Diseases Market From 2025 To 2029?
There has been substantial growth in the market size of pleural diseases in the past few years. With an expected rise from $4.86 billion in 2024 to $5.23 billion in 2025, it is set to experience a compound annual growth rate (CAGR) of 7.6%. This growth during the prior period can be tied to factors such as the growing number of cases of pleural effusion, enhanced awareness of pleural diseases, an increased emphasis on early detection, amplification of healthcare facilities, and a surge in clinical trials related to pleural diseases.
Expectations are high for robust expansion in the pleural diseases market size in the coming years, with a projection to reach $6.94 billion by 2029, having a compound annual growth rate (CAGR) of 7.3%. This anticipated increase within the forecast period is linked to several factors including an upsurge in pleural diseases prevalence, an aging population trend, growing instances of occupational hazards, an escalation in clinical trials, and the proliferation of diagnostic centers. Key trends projected for this period include enhancements in diagnostic procedures and tools, the embracing of less invasive procedures, boosts in drug development, and the implementation of telemedicine.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pleural Diseases Market?
The rise in the occurrence of infectious diseases is projected to instigate the expansion of the pleural diseases market in the future. Such diseases, triggered by harmful microorganisms including bacteria, viruses, fungi, or parasites, are influenced by shifts in human behavior and advancements in international travel. Certain infectious diseases, like bacterial pneumonia, tuberculosis, or viral infections, could lead to pleural disease by inciting inflammation, infection, or fluid buildup in the pleural cavity. For example, in January 2023, the National Library of Medicine, which is a US-based medical library for research and information, reported that infectious diseases are responsible for over 52 million deaths yearly, putting half of the world’s population in danger. Moreover, around 14 million children less than five years of age die each year, with 70% of these deaths linked to preventable diseases through vaccination. Thus, the escalating occurrence of infectious diseases fuels the advancements in the pleural diseases market.
Which Key Market Segments Comprise the Pleural Diseases Market and Drive Its Revenue Growth?
The pleural diseases market covered in this report is segmented –
1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types
2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions
3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy
4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions
Subsegments:
1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy
2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax
3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma
4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma
5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp
Which Areas Are Leading Regions in the Pleural Diseases Market Expansion Across the Globe?
North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in thePleural Diseases Market Over the Coming Years?
Top firms in the pleural diseases market are channeling their efforts into creating innovative treatments, including ready-to-use injectable medicines, with an aim to elevate convenience, cut down on preparation time, and limit dosage mistakes. These injectable solutions come pre-mixed and pre-diluted, making them ready for use without needing any additional reconstitution or mixing. This ensures precision, simplicity and a quicker preparation period. For instance, in April 2024, Amneal Pharmaceuticals, an American pharmaceutical firm, introduced PEMRYDI RTU, the first-of-its-kind ready-to-use version of pemetrexed for injection. This offers individuals suffering from pleural diseases a handy, ready-to-use treatment that eliminates the reconstitution or dilution process, abbreviates preparation time, curtails the possibility of dosage mistakes, and enhances availability to effective treatment for diseases like malignant pleural mesothelioma.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report
How Is the Pleural Diseases Market Conceptually Defined?
Pleural diseases refer to a group of conditions that affect the pleura, which is the double-layered membrane surrounding the lungs. These diseases can involve inflammation, infection, or other pathological pleural changes. Pleural diseases cause chest pain, shortness of breath, coughing, and difficulty breathing and are often diagnosed with imaging tests such as chest X-rays or CT scans.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
